Pharmascience Canada Launches pms-DIMETHYL FUMARATE for the Treatment of Relapsing Remitting Multiple Sclerosis!

Pharmascience Canada, one of Pharmascience Inc division,  is proud to launch PRpms-DIMETHYL FUMARATE, a generic drug with demonstrated bioequivalence to the brand name TECFIDERATM for the treatment of relapsing remitting MS to reduce the frequency of clinical exacerbations and to delay the progression of disability. This product is presented as a delayed release capsule of dimethyl fumarate.


With the same safety and efficacy profile as the brand-name product, PRpms-DIMETHYL FUMARATE is available at a lower cost and offers a patient support program to assist patients in their treatment journey.


“Canada leads the world with one of the highest rates of Multiple Sclerosis per capita (MS)[1]. With the launch of PRpms-DIMETHYL FUMARATE, the lower cost alternative to TECFIDERATM, Pharmascience continues to lead in launching lower cost alternative solutions in MS, expanding access and making medicines more affordable. Our commitment to patients with MS both in Canada and globally is strong and will continue to grow.” – Al Moghaddam, Vice President and General Manager of Pharmascience Canada.



Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries.

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2020, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People and named as one of Montreal’s best employers, as part of the Canada’s Top 100 Employers project. Also, in 2020, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers.


TECFIDERA® is a registered trademark of Biogen Idec Canada Inc. 



For product information, please contact Pharmascience’s Medical Information Department at 1-888-550-6060.

[1] M.S. Society of Canada

Published in

Product Launches